Health Law Diagnosed: Mintz IRA Update — Q3 2025 Edition

Health Law Diagnosed: Mintz IRA Update — Q3 2025 Edition

From Mintz On Air by Mintz

September 22, 2025 · 29 min · Episode 94

About this episode

Bridgette Keller and Hassan Shaikh discuss developments in the IRA and drug pricing, including Medicare negotiations and patient impacts.

In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate Hassan Shaikh for a discussion on noteworthy developments relating to the IRA and drug pricing. Together, Bridgette and Hassan explore: The expansion and evolution of the Medicare Drug Price Negotiation Program Court challenges to the Negotiation Program Drug pricing reform and the OBBBA Impacts on patients and hospitals related to Medicare Part D, 340B, and OPPS clawbacks The rise of direct-to-consumer drug sales models Bridgette and Hassan cut through the complexity and provide an overview of these topics, which are covered in greater depth in the Q3 2025 Edition of the Mintz IRA Update.

People in this episode

Host: Bridgette Keller

Guest: Hassan Shaikh

Topics covered

  • Medicare Drug Price Negotiation Program
  • drug pricing reform
  • court challenges
  • patient impacts
  • direct-to-consumer drug sales

Keywords

  • IRA
  • drug pricing
  • Medicare
  • court challenges
  • 340B
  • OPPS clawbacks
  • direct-to-consumer

Mentioned in this episode

Organizations: Medicare, OBBBA, Mintz

More episodes of Mintz On Air

Explore listener stats, chart rankings, contacts and more on the Mintz On Air podcast page.